Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Posts Tagged ‘memorial’

« Older Entries

Advances in Breast Cancer Research — Sloan-Kettering

By on Friday, May 10th, 2013 | No Comments

Surgical pathologist Jorge Reis-Filho of Memorial Sloan-Kettering explains that microarray “gene chips” could be used to identify breast cancer patients who …

Read More...

Looking for New Targets in Breast Cancer Treatment

By on Thursday, May 9th, 2013 | No Comments

For many years, doctors relied on a breast tumor’s hormone and HER2 protein receptor status to select the appropriate therapy, says Memorial Sloan-Kettering breast surgeon Tari King. Breast…

Read More...

Changes in Breast Cancer Treatment

By on Thursday, May 9th, 2013 | No Comments

Memorial Sloan-Kettering breast surgeon Tari King says that understanding the biology of an individual tumor and its risk of recurrence is changing the way d…

Read More...

Regain and Retain Independence: Rehabilitation During and After Cancer

By on Thursday, April 18th, 2013 | No Comments

Join the Memorial Sloan-Kettering Cancer Center Rehabilitation Service experts for a comprehensive discussion of the services we offer — including rehabilit…

Read More...

Study finds antidepressant helps relieve pain from chemotherapy

By on Thursday, April 4th, 2013 | No Comments

The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful numbness and tingling feelings caused by chemotherapy in 59 percent of patients, a new study led by University of Michigan Comprehensive Cancer Center researchers finds. This is the first clinical trial to find an effective treatment for this pain. Other NCI-designated Cancer Centers or host universities involved in the study were: Duke University, Memorial Sloan-Kettering Cancer Center, Dartmouth-Hitchcock Medical Center, and Ohio State University.

Read More...

Leukemia Cure Possibly Found in Potentially Major Medical Breakthrough

By on Sunday, March 24th, 2013 | No Comments

Memorial Sloan-Kettering researchers genetically alters patients’ own immune cells to fight a deadly form of leukemia. For more GMA, click here: http://gma.y…

Read More...

Pleural Mesothelioma Patients Wanted to Test Novel Treatment in Memorial Sloan-Kettering Cancer Center Clinical Trial

By on Tuesday, March 5th, 2013 | No Comments

Doctors at the Memorial Sloan-Kettering Cancer Center in New York have recently been conducting a clinical trial to test a Wilms Tumor-1 (WT1) vaccine to see if it delays or prevents malignant pleural mesothelioma from growing back after surgery. Don Smitley, a mesothelioma survivor, was a participant in that trial. Now, researchers at MSKCC have …

Read More...

‘Val dreamt of opening a tea room’

By on Tuesday, February 26th, 2013 | No Comments

Val’s Tearoom has officially opened at The Aurora Wellbeing Centre. Manageress Karen Morris serves tea to clients ; Doreen Smith, Chris Bloomer, Kath Inman,Angela Edson and Trish Wright There’s a new tea room in town at the Aurora Wellbeing Centre on Memorial Avenue, ready to welcome you with a hot brew and a friendly smile.

Read More...

Phase II Trial Shows Selumetinib Reverses Radioiodine Resistance In Some Advanced Thyroid Cancers

By on Saturday, February 16th, 2013 | No Comments

The experimental drug selumetinib may allow some patients with advanced thyroid cancer to overcome resistance to radioiodine (RAI), the most effective therapy for the disease, according to new research from Memorial Sloan-Kettering Cancer Center…

Read More...

PIMCO Founder Donates $2 Million to Hoag for Breast Cancer

By on Wednesday, February 6th, 2013 | No Comments

Hoag Memorial Hospital Presbyterian has received a $2 million donation from Bill and Sue Gross to help expand the work of Hoag Hospital breast cancer surgeon and researcher Dr.

Read More...
« Older Entries